24-hour diastolic blood pressure average real variability predicts renal progression in diabetic kidney disease: a comprehensive cohort study - Top-Institutions - MDSpire

24-hour diastolic blood pressure average real variability predicts renal progression in diabetic kidney disease: a comprehensive cohort study

  • By

  • Yanqing Hu

  • Shan Ma

  • Ting Yu

  • Dan Wu

  • Yang Wu

  • April 20, 2026

  • 0 min

Share

Top Institutions in Nephrology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Nephrology
    • Hypertension
    • Diabetes

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Nephrology
    • Hypertension
    • Epidemiology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Nephrology
    • Endocrinology
    • Hypertension

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Nephrology
    • Hypertension
    • Cardiology

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Nephrology
    • Hypertension
    • Diabetes

Original Source(s)

24-hour diastolic blood pressure average real variability predicts renal progression in diabetic kidney disease: a comprehensive cohort study

  • by Yanqing Hu, Shan Ma, Ting Yu, Dan Wu, Yang Wu

  • April 20, 2026

Related Content

Child Opportunity Index and Prevalence of Obesity and Hypertension in Adolescents with Congenital Heart Disease

The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

The Predictive Value of Albumin-to-Creatinine Ratio on Mortality and Its Mediation in Metabolic Dysfunction-Associated Steatotic Liver Disease Among U.S. Adults: Insights from NHANES 1999–2018